Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၀.၂၁%
၁,၀၉၁.၅၁
-၂.၃၀
-၀.၂၁%
—၁,၀၉၃.၈၁၁,၀၉၆.၅၂၁,၁၀၀.၂၂၁,၀၉၁.၅၁——
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၂%
၆၁၀.၁၁
+၁.၃၄
+၀.၂၂%
—၆၀၈.၇၇၆၀၈.၇၇၆၁၂.၉၇၆၀၈.၇၇——
SIXE
Energy
SIXE
Energy
SIXE
-၁.၃၄%
၁,၂၃၇.၉၈
-၁၆.၈၃
-၁.၃၄%
—၁,၂၅၄.၈၁၁,၂၅၃.၀၁၁,၂၅၃.၈၇၁,၂၂၆.၃၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၉၃%
၁,၇၄၄.၇၁
-၁၆.၄၀
-၀.၉၃%
—၁,၇၆၁.၁၁၁,၇၆၄.၂၇၁,၇၆၆.၈၈၁,၇၄၄.၇၁——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၇%
၆၄၀.၁၈
-၂.၄၀
-၀.၃၇%
—၆၄၂.၅၈၆၄၄.၈၇၆၄၈.၄၈၆၄၀.၁၈——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၁၈%
၈၄၉.၅၈
-၁.၅၅
-၀.၁၈%
—၈၅၁.၁၃၈၅၅.၆၆၈၅၈.၇၅၈၄၅.၅၆——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၂၃%
၂၁၇.၄၈
-၀.၅၀
-၀.၂၃%
—၂၁၇.၉၈၂၁၇.၉၈၂၁၈.၆၅၂၁၆.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
+၁.၅၂%
၃,၂၆၀.၆၉
+၄၈.၈၆
+၁.၅၂%
—၃,၂၁၁.၈၃၃,၂၂၇.၂၁၃,၂၆၈.၃၈၃,၂၂၆.၅၅——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၆၉%
၉၄၂.၄၅
-၆.၅၃
-၀.၆၉%
—၉၄၈.၉၈၉၄၈.၅၈၉၅၇.၈၃၉၄၁.၉၇——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၅၂%
၁,၄၆၆.၈၀
-၇.၇၂
-၀.၅၂%
—၁,၄၇၄.၅၂၁,၄၇၉.၀၃၁,၄၈၁.၀၄၁,၄၆၆.၈၀——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၂%
၂,၃၉၇.၅၀
+၅.၃၈
+၀.၂၂%
—၂,၃၉၂.၁၂၂,၃၉၆.၉၅၂,၄၂၁.၂၂၂,၃၈၂.၃၂——
PACK:IDX
Abadi Nusantara Hijau Investama Tbk PT
၂၁၄.၀၀ IDR
-၆.၉၆%
(-၁၆.၀၀) 1D
ဧ ၃၀, GMT+၇ ၁၆:၁၄:၃၄  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for PACK...
Open
၂၃၀ IDR
High
၂၃၄ IDR
Low
၂၁၀ IDR
Mkt. cap
ဋေ ၆.၉၃ သိန်း
Avg. vol.
၂၁.၁၀ ကုဋေ
Volume
၁၈.၂၆ ကုဋေ
P/E ratio
၁၀.၇၅
52-wk high
၄,၉၇၀ IDR
52-wk low
၁၄၃ IDR
EPS
၂၀ IDR
Shares outstanding
ဋေ ၃.၂၄ ထ
No. of employees
၄
News stories
From sources across the web
MSN
MSN
·
ပြီးခဲ့သည့် ၁ မိနစ်
S&P 500 profits haven’t been this rich in at least 15 years — but there’s more to the story
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ နာရီ
Capricor Therapeutics (CAPR) Is Down 12.4% After New HOPE-3 Deramiocel Phase 3 Data Release - What's Changed
Fox News
Fox News
·
ပြီးခဲ့သည့် ၂ နာရီ
May Day agitators ARRESTED after chaining themselves to NYSE
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
Buying record highs looks riskier in the Nasdaq and Russell 2000 than in the broader market: Chart of the Day
About Abadi Nusantara Hijau Investama Tbk PT
CEO-
Employees၄
Founded၂၀၁၉
Headquarters-
SectorMaterial
Websiteflexypack.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
ဋေ ၁.၀၃ ထ
ဋေ ၁.၀၃ ထ
-
ဋေ ၁.၆၉ သ
Cost of goods sold
၈၅၉.၄၀ ဋေ
၈၅၉.၄၀ ဋေ
-
ဋေ ၁.၆၆ သ
Cost of revenue
၈၅၉.၄၀ ဋေ
၈၅၉.၄၀ ဋေ
-
ဋေ ၁.၆၆ သ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
၈၇.၄၈ ကုဋေ
Operating expense
-
-
-
ဋေ ၁.၈၂ ထ
Total operating expenses
၈၅၉.၄၀ ဋေ
၈၅၉.၄၀ ဋေ
-
ဋေ ၁.၈၄ သ
Operating income
၁၆၈.၀၉ ဋေ
၁၆၈.၀၉ ဋေ
-
-ဋေ ၁.၅၃ ထ
Other non operating income
-၅.၀၀ သောင်း
-၅.၀၀ သောင်း
-
-၇.၃၉ သန်း
EBT including unusual items
၁၆၈.၁၃ ဋေ
၁၆၈.၁၃ ဋေ
-
ဋေ ၂.၁၀ ထ
EBT excluding unusual items
၁၆၈.၁၃ ဋေ
၁၆၈.၁၃ ဋေ
-
ဋေ ၂.၁၀ ထ
Income tax expense
၃၆.၉၈ ကုဋေ
၃၆.၉၈ ကုဋေ
-
၅၆.၃၉ ကုဋေ
Effective tax rate
၂၁.၉၉%
၂၁.၉၉%
-
၂.၆၉%
Other operating expenses
-
-
-
ဋေ ၁.၇၃ ထ
Net income
၁၂၉.၈၄ ဋေ
၁၂၉.၈၄ ဋေ
-
ဋေ ၂.၀၄ ထ
Net profit margin
၁၂.၆၄%
၁၂.၆၄%
-
၁၂.၀၆%
Earnings per share
-
-
-
-
Interest and investment income
၄.၆၀ သိန်း
၄.၆၀ သိန်း
-
၃၀.၁၂ ကုဋေ
Interest expense
-
-
-
-၁.၈၁ ကုဋေ
Net interest expenses
၄.၆၀ သိန်း
၄.၆၀ သိန်း
-
၂၈.၃၁ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၂၁၈.၄၂ ဋေ
၂၁၈.၄၂ ဋေ
-
-ဋေ ၁.၅၀ ထ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer